MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Rallybio Corporation Common Stock

RLYB

#3541
Rallybio Corporation Common Stock
7.54
+22.40%
Sector:
Base:
Profit Currency:
Daily Range
7.54
7.54
Year Range
0.22
6.17
Daily Change
+22.40%
Monthly Change
+1096.83%
6 month change
+1246.43%
Year Change
+947.22%
Previous Close
6.16
Open
7.54
Bid
Ask
Low
7.54
High
7.54
Volume
3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. RLYB
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
RLYB
2026.02.24
Lieber, Rallybio CFO, sells $3992 in shares
Investing Investing
RLYB
2026.02.17
Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor
Investing Investing
RLYB
2026.02.03
Rallybio announces one-for-eight reverse stock split effective Feb 6
TipRanks TipRanks
ATOS SXTC RLYB
2026.02.01
Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com
Investing Investing
RLYB
2026.01.29
Rallybio to implement 1-for-8 reverse stock split effective February 6
Investing Investing
RLYB
2025.09.25
Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study
The Motley Fool The Motley Fool
RXRX RLYB
2025.07.08
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Investing Investing
RXRX RLYB
2025.07.08
Recursion Pharmaceuticals stock soars after acquiring HPP treatment from Rallybio
Benzinga Benzinga
RLYB RXRX
2025.07.08
Why Is Microcap Rallybio Stock Trading Higher On Tuesday? - Rallybio (NASDAQ:RLYB), Recursion Pharmaceuticals (NASDAQ:RXRX)
Investing Investing
RLYB
2025.07.08
Rallybio sells HPP treatment program to Recursion for up to $25 million
Investing Investing
RLYB
2025.06.12
Rallybio begins dosing in phase 1 study of C5 inhibitor RLYB116
Benzinga Benzinga
GM HCA IRWD RLYB MBLY
2025.04.15
This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - General Motors (NYSE:GM), HCA Healthcare (NYSE:HCA)

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd